Latest From Mendor Ltd.
Mendor Ltd. says it’s unique in the diabetes space because it has integrated its diagnostic blood glucose meter Discreet with a software application for tailoring patient pharmaceutical treatment. Using the device, which contains a built-in lancing pen and cartridge within a cell-phone-sized plastic cover, diabetics can take their glucose readings in less than 20 seconds, even on the run.
This Month's Profile Groups: Ocular Gene Therapy Sees The Light, features profiles of Avalanche Biotechnologies, Eyevensys, GenSight Biologics, and Hemera Biosciences; Smart Orthopedic Implants, feature profiles of OrthoData and Ortho-tag. Plus these Start-Ups Across Health Care: Colibri Heart Valve, Complix, Helmedix, Mapi Pharma, Mendor, Oligomerix, QuantuMDx, Silicon BioDevices, and Vigilant Biosciences.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
In Vitro Diagnostics
- Glucose Testing
- Monitoring Equipment & Devices
- Therapeutic Areas
- Metabolic Disorders
- Mendor Oy
- Western Europe
- Parent & Subsidiaries
- Mendor Ltd.
- Senior Management
Kristian Ranta, CEO
Heikki Uurto, CFO
Antti Virkamaki, MD, Medical Director
Paul Mordente, Chief Commercial Officer
- Contact Info
Phone: 9 315 77 300
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.